Revenue Insights
by Corinne Cavanaugh, Founder & Growth Advisor
|
TLDR: It takes more than a great product.
If you build it, buyers will not come.
I know that's not what founders want to hear. Especially after the capital raises, the late nights, the product iterations. But here's what I see repeatedly: founders pour capital into product development, thinking that if the product is amazing enough, the market will find it. So they neglect to invest in marketing, and they pay for it.
In the beginning, a founder with a genuinely solid product uses a network of warm relationships and hustle energy to land the first few clients. There's momentum, and additional customers come. Then growth plateaus. Prospects stop converting; the network has been tapped. The product is still great, but here's the root cause of the problem. There's no system behind marketing: no defined segments, no economic value story, no activation plan, no commercial team readiness.
At some point, founders become their own ceiling, and the companies that break through that ceiling are the ones who make the decision, before they are desperate, to invest in marketing as a revenue function.
The question worth asking this month is: What systems could you put in place to flood your pipeline and improve your close rate so that it would be unreasonable for your revenue not to grow?
Learn: Why product launches stall...
Advice from Angela Martin, a commercialization leader who has powered $52M+ in product launches at PepsiCo, Mayo Clinic, and Harley-Davidson.
|
Angela Martin has launched products in two of the most demanding commercial environments that exist: Consumer Product Goods and healthcare. What she's found is that the obstacles and failures are almost always the same for both industries.
Angela reveals the truth about why launches stall:
"I think the number one reason launches stall is that companies confuse product readiness with commercial team readiness. Engineering? Great, they're done. Product managers? Great, they're done. Marketing? You got your positioning down. Lateral sales, you get trained at the end, and then boom, you expect everyone to be ready and revenue should follow. But revenue is not a byproduct of a launch. It's the result of activation. A lot of activation."
That gap between product-ready and revenue-ready, Angela says, shows up in three consistent places: no clear definition of the primary revenue segment, no quantified economic case for the buyer, and no 90-day activation plan that aligns sales and marketing before launch.
Her fix is a bridge.
"When I lead launches, I like to focus on building that bridge from development all the way to revenue. That bridge includes having a clear target, a clear use case, the economic value articulated clearly in a way that sales is not just informed but sales has punched it a bit, and they feel like, yes, I can actually defend this. Then pre-launch sales enablement that arms the sales team not just with what marketing thinks is great materials, but with what the sales team is feeling empowered by."
The anchor principle Angela returns to across every industry, every company size, every product: "A launch is not a date. It's a revenue event."
What sells in CPG and healthcare?
The buying dynamics are completely different. In CPG, you're optimizing for velocity and emotional pull: one buyer, low risk, influenced by brand and price. In healthcare, you're selling into layered risk with clinicians, administrators, procurement, finance, and sometimes regulatory all in the room.
Is there a principle that stays constant across both?
"Commercialization succeeds or fails based on clarity and alignment. Whether I was at PepsiCo or leading commercialization at Mayo Clinic Laboratories, the work always starts with defining that one clear problem and one clear economic value story. If the internal teams, sales and marketing, can't articulate the value in that same language, the market won't hear it clearly either."
Failures in both worlds: "Leaders get trapped when they believe that the product being done means the market is ready. But it's more complex than that. The constant across industries is that revenue accelerates when the organization aligns behind one clear, defensible value story. Sales and marketing singing from that same sheet of music is what gets you there."
Want more from Angela, but only have 5 minutes?
COMING MONDAY!
Lightning Speed Podcast
Marketing leaders who engineered revenue growth at Fortune 500 companies share blueprints to help SMBs grow quickly. In each episode, a CMO who has worked with both SMBs and companies including Disney, Microsoft, Estée Lauder, PepsiCo, Wizards of the Coast and more, shares their learnings and systems for acquiring customers, reducing churn, and scaling revenue.
|
|
|
Pulse: Marketing Moves
What the industry is talking about and how ambitious companies can use the information.
|
RevOps is replacing the traditional marketing org, and it's showing up in revenue results
Organizations achieving full sales and marketing alignment report 38% higher win rates, according to Aberdeen Group research. The 2026 trend dominating boardroom conversations is the shift toward Revenue Operations, a unified framework that brings marketing, sales, and customer success under shared metrics and shared accountability. Traditional structures created friction: different data sets, disconnected tools, and conflicting success metrics that produced disjointed customer experiences and inefficient resource allocation. The companies moving fastest are the ones replacing MQL counts with pipeline contribution, win rates, and customer lifetime value as the measures of marketing performance.
What this means for you. It's time to embrace an AI-first marketing department. That means systems, integrations, human gates, SOPs, and technology adoption to support effectiveness and quality. The tech is there, the connectors make it easy, and the data supports the decision to invest in it.
The buying committee just got bigger
Buying committees have expanded to an average of six to ten decision-makers per B2B purchase, according to Gartner research. Sales cycles have lengthened as buyers conduct more independent research before engaging with vendors. More than half of large B2B purchases will be processed through digital self-serve channels, including vendor websites and marketplaces; a fundamental shift away from sales-rep-mediated transactions. Buyers want to configure, evaluate, and decide before they ever talk to a salesperson.
What this means for you. The way people conduct research has changed. Ranking high on a SERP page is becoming less and less relevant. Investment in AEO and GEO is required. Trials and demos are more important than ever.
Authenticity for the win
In a sea of formulaic messaging and mass-produced AI copy, audiences in 2026 are responding to stories with substance. Case studies, original research, and first-hand expertise are outperforming generic posts and keyword-heavy content. As AI-generated content floods B2B channels, maintaining voice and quality has emerged as a top challenge for 39% of marketers.
What this means for you: Don't let your team get lazy. The brands winning attention right now are the ones that sound unmistakably human, specific, and credible. Be sure every piece of content generated and published has substance and meets high-quality standard.
Cheering for you,
Corinne
